Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02107482 · ClinicalTrials.gov registry record · NA
Use of Localized NB-UVB (Levia®) in the Treatment of Plaque-psoriasis
A NA study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02107482 is a NA study that has completed, run by Tufts Medical Center. The registered enrollment target is 21 participants.
The verdict
NCT02107482, a NA study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of the study is to test the effect of a localized narrow band ultraviolet (NB-UVB) phototherapy compared to visible light that does not produce UVB on the clearance of psoriasis plaques and resolution of itching. Localized NB-UVB (Levia®) phototherapy device is cleared by the U.S Food and Drug Administration (FDA).
Interventions
- DEVICE Levia Narrow Band UVB
- DEVICE Levia sham/visible-light source
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02107482
The ClinicalTrials.gov registry entry for NCT02107482 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Levia Narrow Band UVB is the first listed.
NCT02107482 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02107482 about?
NCT02107482 is a clinical study titled "Use of Localized NB-UVB (Levia®) in the Treatment of Plaque-psoriasis". The purpose of the study is to test the effect of a localized narrow band ultraviolet (NB-UVB) phototherapy compared to visible light that does not produce UVB on the clearance of psoriasis plaques and resolution of itching. Localized NB-UVB (Levia®) phototherapy device is cleared by the U.S Food an...
What is the current status of trial NCT02107482?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2011-12. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02107482?
The interventions under investigation include: Levia Narrow Band UVB (DEVICE), Levia sham/visible-light source (DEVICE).
Who is sponsoring clinical trial NCT02107482?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.